Is Carotid Intima-media Thickness Affected by A1C Variability?

This study has been completed.

Sponsor:

Information provided by:

Yonsei University

ClinicalTrials.gov Identifier:

NCT00842972

First received: February 11, 2009

Last updated: September 14, 2009

Last verified: September 2009

History of Changes

Tracking Information
First Received Date ^ICMJE	February 11, 2009
Last Updated Date	September 14, 2009
Start Date ^ICMJE	Not Provided
Primary Completion Date	Not Provided
Current Primary Outcome Measures ^ICMJE	Not Provided
Original Primary Outcome Measures ^ICMJE	Not Provided
Change History	Complete list of historical versions of study NCT00842972 on ClinicalTrials.gov Archive Site
Current Secondary Outcome Measures ^ICMJE	Not Provided
Original Secondary Outcome Measures ^ICMJE	Not Provided
Current Other Outcome Measures ^ICMJE	Not Provided
Original Other Outcome Measures ^ICMJE	Not Provided

Descriptive Information
Brief Title ^ICMJE	Is Carotid Intima-media Thickness Affected by A1C Variability?
Official Title ^ICMJE	Not Provided
Brief Summary	This study was conducted to evaluate the effect of A1C variability on the progression of carotid artery intima-media thickness in type 2 diabetic patients.
Detailed Description	Not Provided
Study Type ^ICMJE	Observational
Study Design ^ICMJE	Observational Model: Cohort Time Perspective: Prospective
Target Follow-Up Duration	Not Provided
Biospecimen	Not Provided
Sampling Method	Probability Sample
Study Population	typeII, Fluroscopy in carotid once a year during 2 years.
Condition ^ICMJE	Type 2 Diabetes A1C Variability
Intervention ^ICMJE	Not Provided
Study Group/Cohort (s)	Not Provided
Publications *	Not Provided
* Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.

Recruitment Information
Recruitment Status ^ICMJE	Completed
Enrollment ^ICMJE	Not Provided
Completion Date	Not Provided
Primary Completion Date	Not Provided
Eligibility Criteria ^ICMJE	Inclusion Criteria: type II fluoroscopy in carotid once a year during 2 years Exclusion Criteria: type 1 diabetes history or clinical evidence of coronary artery disease or cerebral or peripheral vascular disease the presence of albuminuria (defined as 24 hour urine albumin excretion ≥ 30 mg) renal dysfunction (defined as creatinine blood level ≥ 2.0 mg/dL) hepatic dysfunction (defined as alanine aminotransferase and/or aspartate aminotransferase blood level ≥ 3 × upper normal limit) smoking within the past 3 months prior to commencement of the study use of any medication likely to alter IMT such as calcium channel blocker, thiazolidinedione, antiplatelet agent (clopidogrel, cilostazol) use of glucocorticoid pregnancy severe concomitant disease such as cancer infection Cushing's syndrome acromegaly, or any other disorder likely to alter glycemia primary hypercholesterolemia hypothyroidism or hyperthyroidism use of any hormonal drugs alcoholism or drug abuse
Gender	Both
Ages	34 Years to 79 Years
Accepts Healthy Volunteers	No
Contacts ^ICMJE	Contact information is only displayed when the study is recruiting subjects
Location Countries ^ICMJE	Not Provided

Administrative Information
NCT Number ^ICMJE	NCT00842972
Other Study ID Numbers ^ICMJE	3-2006-0005
Has Data Monitoring Committee	Not Provided
Responsible Party	Ahn, Chul Woo, Gangnam Severance Hospital
Study Sponsor ^ICMJE	Yonsei University
Collaborators ^ICMJE	Not Provided
Investigators ^ICMJE	Not Provided
Information Provided By	Yonsei University
Verification Date	September 2009
^ICMJE Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP

To Top